Genomic research has found the endangered hoiho is made up of three distinct subspecies, a discovery that may help guard ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed high lysolipid levels in those with acute respiratory distress syndrome (ARDS), which may ...

Important new genetic research reveals that New Zealand's bird of the year is actually three subspecies, and this could help ...

Edesa Biotech has announced positive results from a Phase III clinical trial of its drug candidate, paridiprubart (EB05), for ...

Edesa Biotech has shared data from its truncated phase 3 respiratory failure trial, linking the anti-TLR4 antibody to ...

The use of intravenous magnesium sulphate for acute respiratory distress syndrome is associated with a lower rate of ...

And it turns out there's a good reason why we feel relief after big breaths, It comes down to a special fluid inside our lungs. The liquid -- pulmonary surfactant -- helps our lungs work. Without it, ...

Bayer has dropped an acute respiratory distress syndrome drug in phase 2 development for “scientific reasons,” the German pharma giant revealed in its latest earnings results. The company “decided not ...

Study met primary and secondary endpointsParidiprubart demonstrated a relative reduction in the risk of death of 25%Treatment provided patients ...